nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—coronary artery disease—atherosclerosis	0.566	1	CtDrD
Niacin—SLC16A1—Pravastatin—atherosclerosis	0.117	0.387	CbGbCtD
Niacin—SLCO2B1—Rosuvastatin—atherosclerosis	0.0805	0.267	CbGbCtD
Niacin—SLCO2B1—Pravastatin—atherosclerosis	0.0733	0.243	CbGbCtD
Niacin—CYP2D6—Simvastatin—atherosclerosis	0.0105	0.0347	CbGbCtD
Niacin—CYP2D6—Lovastatin—atherosclerosis	0.0102	0.0339	CbGbCtD
Niacin—CYP2D6—Pravastatin—atherosclerosis	0.0102	0.0339	CbGbCtD
Niacin—HCAR2—connective tissue—atherosclerosis	0.00204	0.166	CbGeAlD
Niacin—HCAR2—adipose tissue—atherosclerosis	0.00156	0.127	CbGeAlD
Niacin—QPRT—liver—atherosclerosis	0.00131	0.107	CbGeAlD
Niacin—NNMT—connective tissue—atherosclerosis	0.00115	0.0934	CbGeAlD
Niacin—Raised liver function tests—Pravastatin—atherosclerosis	0.00101	0.0174	CcSEcCtD
Niacin—NNMT—cardiovascular system—atherosclerosis	0.000997	0.0813	CbGeAlD
Niacin—Myopathy—Rosuvastatin—atherosclerosis	0.00093	0.016	CcSEcCtD
Niacin—NNMT—adipose tissue—atherosclerosis	0.000879	0.0717	CbGeAlD
Niacin—Cholelithiasis—Ezetimibe—atherosclerosis	0.000872	0.015	CcSEcCtD
Niacin—Myopathy—Lovastatin—atherosclerosis	0.000788	0.0135	CcSEcCtD
Niacin—Myopathy—Ezetimibe—atherosclerosis	0.000773	0.0133	CcSEcCtD
Niacin—Myopathy—Simvastatin—atherosclerosis	0.000737	0.0127	CcSEcCtD
Niacin—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.000737	0.0127	CcSEcCtD
Niacin—Cough increased—Rosuvastatin—atherosclerosis	0.000712	0.0122	CcSEcCtD
Niacin—SLC16A3—cardiovascular system—atherosclerosis	0.000681	0.0555	CbGeAlD
Niacin—Heartburn—Pravastatin—atherosclerosis	0.000679	0.0117	CcSEcCtD
Niacin—Myopathy—Pravastatin—atherosclerosis	0.000666	0.0115	CcSEcCtD
Niacin—Jaundice cholestatic—Lovastatin—atherosclerosis	0.000629	0.0108	CcSEcCtD
Niacin—Rhabdomyolysis—Lovastatin—atherosclerosis	0.000625	0.0107	CcSEcCtD
Niacin—NNMT—liver—atherosclerosis	0.000616	0.0503	CbGeAlD
Niacin—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.000613	0.0105	CcSEcCtD
Niacin—SLC16A3—adipose tissue—atherosclerosis	0.0006	0.049	CbGeAlD
Niacin—Bone disorder—Ezetimibe—atherosclerosis	0.0006	0.0103	CcSEcCtD
Niacin—Jaundice cholestatic—Simvastatin—atherosclerosis	0.000588	0.0101	CcSEcCtD
Niacin—Rhabdomyolysis—Simvastatin—atherosclerosis	0.000584	0.01	CcSEcCtD
Niacin—Hypertonia—Rosuvastatin—atherosclerosis	0.000572	0.00983	CcSEcCtD
Niacin—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.000544	0.00936	CcSEcCtD
Niacin—Jaundice cholestatic—Pravastatin—atherosclerosis	0.000532	0.00914	CcSEcCtD
Niacin—Rhabdomyolysis—Pravastatin—atherosclerosis	0.000528	0.00908	CcSEcCtD
Niacin—Hepatic function abnormal—Lovastatin—atherosclerosis	0.000459	0.00789	CcSEcCtD
Niacin—Diabetes mellitus—Simvastatin—atherosclerosis	0.000431	0.00742	CcSEcCtD
Niacin—Hepatic function abnormal—Simvastatin—atherosclerosis	0.000429	0.00738	CcSEcCtD
Niacin—SLC16A3—liver—atherosclerosis	0.000421	0.0343	CbGeAlD
Niacin—Eczema—Simvastatin—atherosclerosis	0.000418	0.00718	CcSEcCtD
Niacin—Muscular weakness—Rosuvastatin—atherosclerosis	0.000418	0.00718	CcSEcCtD
Niacin—SLC16A1—cardiovascular system—atherosclerosis	0.000414	0.0337	CbGeAlD
Niacin—Arthritis—Lovastatin—atherosclerosis	0.000413	0.0071	CcSEcCtD
Niacin—Influenza—Rosuvastatin—atherosclerosis	0.000409	0.00703	CcSEcCtD
Niacin—Arthritis—Ezetimibe—atherosclerosis	0.000405	0.00696	CcSEcCtD
Niacin—Atrial fibrillation—Simvastatin—atherosclerosis	0.000396	0.00681	CcSEcCtD
Niacin—Bronchitis—Rosuvastatin—atherosclerosis	0.000393	0.00676	CcSEcCtD
Niacin—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000388	0.00667	CcSEcCtD
Niacin—Arthritis—Simvastatin—atherosclerosis	0.000386	0.00664	CcSEcCtD
Niacin—SLC16A1—adipose tissue—atherosclerosis	0.000365	0.0297	CbGeAlD
Niacin—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000363	0.00625	CcSEcCtD
Niacin—Jaundice—Rosuvastatin—atherosclerosis	0.000356	0.00611	CcSEcCtD
Niacin—Arthritis—Pravastatin—atherosclerosis	0.000349	0.006	CcSEcCtD
Niacin—Muscular weakness—Ezetimibe—atherosclerosis	0.000347	0.00597	CcSEcCtD
Niacin—Influenza—Lovastatin—atherosclerosis	0.000347	0.00596	CcSEcCtD
Niacin—Influenza—Ezetimibe—atherosclerosis	0.00034	0.00585	CcSEcCtD
Niacin—Muscular weakness—Simvastatin—atherosclerosis	0.000331	0.00569	CcSEcCtD
Niacin—Rhinitis—Rosuvastatin—atherosclerosis	0.000328	0.00564	CcSEcCtD
Niacin—Hepatitis—Rosuvastatin—atherosclerosis	0.000327	0.00563	CcSEcCtD
Niacin—Erectile dysfunction—Lovastatin—atherosclerosis	0.000319	0.00549	CcSEcCtD
Niacin—SLCO2B1—adipose tissue—atherosclerosis	0.000314	0.0256	CbGeAlD
Niacin—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000313	0.00538	CcSEcCtD
Niacin—Liver function test abnormal—Pravastatin—atherosclerosis	0.000313	0.00538	CcSEcCtD
Niacin—Bronchitis—Simvastatin—atherosclerosis	0.000312	0.00536	CcSEcCtD
Niacin—Dry skin—Pravastatin—atherosclerosis	0.000311	0.00535	CcSEcCtD
Niacin—Muscular weakness—Pravastatin—atherosclerosis	0.000299	0.00514	CcSEcCtD
Niacin—Erectile dysfunction—Simvastatin—atherosclerosis	0.000299	0.00514	CcSEcCtD
Niacin—Jaundice—Ezetimibe—atherosclerosis	0.000296	0.00508	CcSEcCtD
Niacin—Abdominal distension—Pravastatin—atherosclerosis	0.000295	0.00507	CcSEcCtD
Niacin—Influenza—Pravastatin—atherosclerosis	0.000293	0.00504	CcSEcCtD
Niacin—Arrhythmia—Rosuvastatin—atherosclerosis	0.000293	0.00503	CcSEcCtD
Niacin—Angina pectoris—Pravastatin—atherosclerosis	0.000286	0.00491	CcSEcCtD
Niacin—Jaundice—Simvastatin—atherosclerosis	0.000282	0.00485	CcSEcCtD
Niacin—Flatulence—Rosuvastatin—atherosclerosis	0.000281	0.00483	CcSEcCtD
Niacin—Hepatitis—Lovastatin—atherosclerosis	0.000278	0.00477	CcSEcCtD
Niacin—Hepatitis—Ezetimibe—atherosclerosis	0.000272	0.00468	CcSEcCtD
Niacin—Erectile dysfunction—Pravastatin—atherosclerosis	0.00027	0.00464	CcSEcCtD
Niacin—Oedema peripheral—Ezetimibe—atherosclerosis	0.000268	0.00461	CcSEcCtD
Niacin—Angioedema—Rosuvastatin—atherosclerosis	0.00026	0.00448	CcSEcCtD
Niacin—Hepatitis—Simvastatin—atherosclerosis	0.00026	0.00446	CcSEcCtD
Niacin—Flushing—Lovastatin—atherosclerosis	0.000258	0.00443	CcSEcCtD
Niacin—SLC16A1—liver—atherosclerosis	0.000256	0.0209	CbGeAlD
Niacin—Jaundice—Pravastatin—atherosclerosis	0.000255	0.00438	CcSEcCtD
Niacin—Flushing—Ezetimibe—atherosclerosis	0.000253	0.00434	CcSEcCtD
Niacin—Chills—Lovastatin—atherosclerosis	0.000249	0.00428	CcSEcCtD
Niacin—Cough—Rosuvastatin—atherosclerosis	0.000249	0.00428	CcSEcCtD
Niacin—Angiopathy—Ezetimibe—atherosclerosis	0.000247	0.00425	CcSEcCtD
Niacin—Alopecia—Lovastatin—atherosclerosis	0.000245	0.00422	CcSEcCtD
Niacin—Arthralgia—Rosuvastatin—atherosclerosis	0.000243	0.00417	CcSEcCtD
Niacin—Myalgia—Rosuvastatin—atherosclerosis	0.000243	0.00417	CcSEcCtD
Niacin—Flushing—Simvastatin—atherosclerosis	0.000241	0.00414	CcSEcCtD
Niacin—Alopecia—Ezetimibe—atherosclerosis	0.000241	0.00414	CcSEcCtD
Niacin—Flatulence—Lovastatin—atherosclerosis	0.000238	0.00409	CcSEcCtD
Niacin—Erythema—Ezetimibe—atherosclerosis	0.000237	0.00407	CcSEcCtD
Niacin—Malnutrition—Ezetimibe—atherosclerosis	0.000237	0.00407	CcSEcCtD
Niacin—Rhinitis—Pravastatin—atherosclerosis	0.000235	0.00404	CcSEcCtD
Niacin—Hepatitis—Pravastatin—atherosclerosis	0.000235	0.00403	CcSEcCtD
Niacin—Hypoaesthesia—Pravastatin—atherosclerosis	0.000234	0.00401	CcSEcCtD
Niacin—Flatulence—Ezetimibe—atherosclerosis	0.000234	0.00401	CcSEcCtD
Niacin—Chills—Simvastatin—atherosclerosis	0.000233	0.004	CcSEcCtD
Niacin—Muscle spasms—Lovastatin—atherosclerosis	0.000232	0.00399	CcSEcCtD
Niacin—Alopecia—Simvastatin—atherosclerosis	0.000229	0.00394	CcSEcCtD
Niacin—Muscle spasms—Ezetimibe—atherosclerosis	0.000228	0.00392	CcSEcCtD
Niacin—Vision blurred—Lovastatin—atherosclerosis	0.000228	0.00391	CcSEcCtD
Niacin—Visual impairment—Pravastatin—atherosclerosis	0.000226	0.00389	CcSEcCtD
Niacin—Erythema—Simvastatin—atherosclerosis	0.000226	0.00388	CcSEcCtD
Niacin—Flatulence—Simvastatin—atherosclerosis	0.000223	0.00383	CcSEcCtD
Niacin—Angioedema—Lovastatin—atherosclerosis	0.000221	0.0038	CcSEcCtD
Niacin—SLCO2B1—liver—atherosclerosis	0.00022	0.0179	CbGeAlD
Niacin—Tinnitus—Pravastatin—atherosclerosis	0.000219	0.00376	CcSEcCtD
Niacin—Flushing—Pravastatin—atherosclerosis	0.000218	0.00374	CcSEcCtD
Niacin—Muscle spasms—Simvastatin—atherosclerosis	0.000217	0.00374	CcSEcCtD
Niacin—Vertigo—Lovastatin—atherosclerosis	0.000217	0.00373	CcSEcCtD
Niacin—Angioedema—Ezetimibe—atherosclerosis	0.000217	0.00372	CcSEcCtD
Niacin—Leukopenia—Lovastatin—atherosclerosis	0.000216	0.00372	CcSEcCtD
Niacin—Vision blurred—Simvastatin—atherosclerosis	0.000213	0.00366	CcSEcCtD
Niacin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000212	0.00364	CcSEcCtD
Niacin—Chills—Pravastatin—atherosclerosis	0.000211	0.00362	CcSEcCtD
Niacin—Insomnia—Rosuvastatin—atherosclerosis	0.00021	0.00362	CcSEcCtD
Niacin—Arrhythmia—Pravastatin—atherosclerosis	0.00021	0.0036	CcSEcCtD
Niacin—Palpitations—Ezetimibe—atherosclerosis	0.000209	0.0036	CcSEcCtD
Niacin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000209	0.00359	CcSEcCtD
Niacin—SLC22A5—adipose tissue—atherosclerosis	0.000208	0.017	CbGeAlD
Niacin—Alopecia—Pravastatin—atherosclerosis	0.000207	0.00357	CcSEcCtD
Niacin—Cough—Ezetimibe—atherosclerosis	0.000207	0.00355	CcSEcCtD
Niacin—Angioedema—Simvastatin—atherosclerosis	0.000206	0.00355	CcSEcCtD
Niacin—Myalgia—Lovastatin—atherosclerosis	0.000206	0.00354	CcSEcCtD
Niacin—Arthralgia—Lovastatin—atherosclerosis	0.000206	0.00354	CcSEcCtD
Niacin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000205	0.00352	CcSEcCtD
Niacin—Vertigo—Simvastatin—atherosclerosis	0.000203	0.00349	CcSEcCtD
Niacin—Leukopenia—Simvastatin—atherosclerosis	0.000202	0.00348	CcSEcCtD
Niacin—Myalgia—Ezetimibe—atherosclerosis	0.000202	0.00347	CcSEcCtD
Niacin—Arthralgia—Ezetimibe—atherosclerosis	0.000202	0.00347	CcSEcCtD
Niacin—Flatulence—Pravastatin—atherosclerosis	0.000201	0.00346	CcSEcCtD
Niacin—Dry mouth—Lovastatin—atherosclerosis	0.000201	0.00346	CcSEcCtD
Niacin—Tension—Pravastatin—atherosclerosis	0.0002	0.00345	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0002	0.00344	CcSEcCtD
Niacin—Pain—Rosuvastatin—atherosclerosis	0.000199	0.00342	CcSEcCtD
Niacin—Nervousness—Pravastatin—atherosclerosis	0.000198	0.00341	CcSEcCtD
Niacin—Dry mouth—Ezetimibe—atherosclerosis	0.000197	0.00339	CcSEcCtD
Niacin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000197	0.00339	CcSEcCtD
Niacin—Muscle spasms—Pravastatin—atherosclerosis	0.000196	0.00338	CcSEcCtD
Niacin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000193	0.00332	CcSEcCtD
Niacin—Vision blurred—Pravastatin—atherosclerosis	0.000193	0.00331	CcSEcCtD
Niacin—Arthralgia—Simvastatin—atherosclerosis	0.000192	0.00331	CcSEcCtD
Niacin—Myalgia—Simvastatin—atherosclerosis	0.000192	0.00331	CcSEcCtD
Niacin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00019	0.00327	CcSEcCtD
Niacin—Anorexia—Lovastatin—atherosclerosis	0.000188	0.00323	CcSEcCtD
Niacin—Skin disorder—Ezetimibe—atherosclerosis	0.000188	0.00323	CcSEcCtD
Niacin—Angioedema—Pravastatin—atherosclerosis	0.000187	0.00321	CcSEcCtD
Niacin—Urticaria—Rosuvastatin—atherosclerosis	0.000185	0.00318	CcSEcCtD
Niacin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000184	0.00317	CcSEcCtD
Niacin—Oedema—Simvastatin—atherosclerosis	0.000184	0.00317	CcSEcCtD
Niacin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000184	0.00316	CcSEcCtD
Niacin—Vertigo—Pravastatin—atherosclerosis	0.000184	0.00316	CcSEcCtD
Niacin—Leukopenia—Pravastatin—atherosclerosis	0.000183	0.00314	CcSEcCtD
Niacin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00018	0.00309	CcSEcCtD
Niacin—Insomnia—Lovastatin—atherosclerosis	0.000178	0.00307	CcSEcCtD
Niacin—Cough—Pravastatin—atherosclerosis	0.000178	0.00306	CcSEcCtD
Niacin—Paraesthesia—Lovastatin—atherosclerosis	0.000177	0.00304	CcSEcCtD
Niacin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000176	0.00303	CcSEcCtD
Niacin—Anorexia—Simvastatin—atherosclerosis	0.000176	0.00302	CcSEcCtD
Niacin—Dyspnoea—Lovastatin—atherosclerosis	0.000176	0.00302	CcSEcCtD
Niacin—Insomnia—Ezetimibe—atherosclerosis	0.000175	0.00301	CcSEcCtD
Niacin—Arthralgia—Pravastatin—atherosclerosis	0.000174	0.00299	CcSEcCtD
Niacin—Myalgia—Pravastatin—atherosclerosis	0.000174	0.00299	CcSEcCtD
Niacin—Paraesthesia—Ezetimibe—atherosclerosis	0.000174	0.00299	CcSEcCtD
Niacin—Dyspepsia—Lovastatin—atherosclerosis	0.000174	0.00298	CcSEcCtD
Niacin—Dyspnoea—Ezetimibe—atherosclerosis	0.000172	0.00296	CcSEcCtD
Niacin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000171	0.00295	CcSEcCtD
Niacin—Decreased appetite—Lovastatin—atherosclerosis	0.000171	0.00295	CcSEcCtD
Niacin—Dyspepsia—Ezetimibe—atherosclerosis	0.00017	0.00293	CcSEcCtD
Niacin—Pain—Lovastatin—atherosclerosis	0.000169	0.0029	CcSEcCtD
Niacin—Decreased appetite—Ezetimibe—atherosclerosis	0.000168	0.00289	CcSEcCtD
Niacin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000168	0.00289	CcSEcCtD
Niacin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000167	0.00287	CcSEcCtD
Niacin—Asthenia—Rosuvastatin—atherosclerosis	0.000167	0.00287	CcSEcCtD
Niacin—Insomnia—Simvastatin—atherosclerosis	0.000167	0.00287	CcSEcCtD
Niacin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000167	0.00287	CcSEcCtD
Niacin—Oedema—Pravastatin—atherosclerosis	0.000167	0.00287	CcSEcCtD
Niacin—Paraesthesia—Simvastatin—atherosclerosis	0.000166	0.00285	CcSEcCtD
Niacin—Pain—Ezetimibe—atherosclerosis	0.000165	0.00284	CcSEcCtD
Niacin—Pruritus—Rosuvastatin—atherosclerosis	0.000165	0.00283	CcSEcCtD
Niacin—Dyspnoea—Simvastatin—atherosclerosis	0.000164	0.00283	CcSEcCtD
Niacin—Dyspepsia—Simvastatin—atherosclerosis	0.000162	0.00279	CcSEcCtD
Niacin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000161	0.00277	CcSEcCtD
Niacin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000161	0.00277	CcSEcCtD
Niacin—Decreased appetite—Simvastatin—atherosclerosis	0.00016	0.00276	CcSEcCtD
Niacin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000159	0.00274	CcSEcCtD
Niacin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000159	0.00274	CcSEcCtD
Niacin—Anorexia—Pravastatin—atherosclerosis	0.000159	0.00273	CcSEcCtD
Niacin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000158	0.00272	CcSEcCtD
Niacin—Pain—Simvastatin—atherosclerosis	0.000158	0.00271	CcSEcCtD
Niacin—Urticaria—Lovastatin—atherosclerosis	0.000157	0.00269	CcSEcCtD
Niacin—Abdominal pain—Lovastatin—atherosclerosis	0.000156	0.00268	CcSEcCtD
Niacin—Body temperature increased—Lovastatin—atherosclerosis	0.000156	0.00268	CcSEcCtD
Niacin—Dizziness—Rosuvastatin—atherosclerosis	0.000154	0.00265	CcSEcCtD
Niacin—Urticaria—Ezetimibe—atherosclerosis	0.000154	0.00264	CcSEcCtD
Niacin—Abdominal pain—Ezetimibe—atherosclerosis	0.000153	0.00263	CcSEcCtD
Niacin—Body temperature increased—Ezetimibe—atherosclerosis	0.000153	0.00263	CcSEcCtD
Niacin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000152	0.00261	CcSEcCtD
Niacin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000151	0.00259	CcSEcCtD
Niacin—Insomnia—Pravastatin—atherosclerosis	0.000151	0.00259	CcSEcCtD
Niacin—Paraesthesia—Pravastatin—atherosclerosis	0.00015	0.00257	CcSEcCtD
Niacin—Dyspnoea—Pravastatin—atherosclerosis	0.000149	0.00256	CcSEcCtD
Niacin—Dyspepsia—Pravastatin—atherosclerosis	0.000147	0.00252	CcSEcCtD
Niacin—Rash—Rosuvastatin—atherosclerosis	0.000147	0.00252	CcSEcCtD
Niacin—Dermatitis—Rosuvastatin—atherosclerosis	0.000147	0.00252	CcSEcCtD
Niacin—Urticaria—Simvastatin—atherosclerosis	0.000147	0.00252	CcSEcCtD
Niacin—SLC22A5—liver—atherosclerosis	0.000146	0.0119	CbGeAlD
Niacin—Body temperature increased—Simvastatin—atherosclerosis	0.000146	0.00251	CcSEcCtD
Niacin—Abdominal pain—Simvastatin—atherosclerosis	0.000146	0.00251	CcSEcCtD
Niacin—Headache—Rosuvastatin—atherosclerosis	0.000146	0.00251	CcSEcCtD
Niacin—Hypersensitivity—Lovastatin—atherosclerosis	0.000145	0.0025	CcSEcCtD
Niacin—Decreased appetite—Pravastatin—atherosclerosis	0.000145	0.00249	CcSEcCtD
Niacin—Pain—Pravastatin—atherosclerosis	0.000143	0.00245	CcSEcCtD
Niacin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000142	0.00245	CcSEcCtD
Niacin—Asthenia—Lovastatin—atherosclerosis	0.000141	0.00243	CcSEcCtD
Niacin—Pruritus—Lovastatin—atherosclerosis	0.00014	0.0024	CcSEcCtD
Niacin—Asthenia—Ezetimibe—atherosclerosis	0.000139	0.00239	CcSEcCtD
Niacin—Nausea—Rosuvastatin—atherosclerosis	0.000138	0.00238	CcSEcCtD
Niacin—Pruritus—Ezetimibe—atherosclerosis	0.000137	0.00235	CcSEcCtD
Niacin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000136	0.00234	CcSEcCtD
Niacin—Hypersensitivity—Simvastatin—atherosclerosis	0.000136	0.00234	CcSEcCtD
Niacin—Diarrhoea—Lovastatin—atherosclerosis	0.000135	0.00232	CcSEcCtD
Niacin—Urticaria—Pravastatin—atherosclerosis	0.000132	0.00228	CcSEcCtD
Niacin—Asthenia—Simvastatin—atherosclerosis	0.000132	0.00227	CcSEcCtD
Niacin—Diarrhoea—Ezetimibe—atherosclerosis	0.000132	0.00227	CcSEcCtD
Niacin—Body temperature increased—Pravastatin—atherosclerosis	0.000132	0.00227	CcSEcCtD
Niacin—Abdominal pain—Pravastatin—atherosclerosis	0.000132	0.00227	CcSEcCtD
Niacin—Pruritus—Simvastatin—atherosclerosis	0.00013	0.00224	CcSEcCtD
Niacin—Dizziness—Lovastatin—atherosclerosis	0.00013	0.00224	CcSEcCtD
Niacin—Dizziness—Ezetimibe—atherosclerosis	0.000128	0.0022	CcSEcCtD
Niacin—Diarrhoea—Simvastatin—atherosclerosis	0.000126	0.00217	CcSEcCtD
Niacin—Vomiting—Lovastatin—atherosclerosis	0.000125	0.00216	CcSEcCtD
Niacin—Rash—Lovastatin—atherosclerosis	0.000124	0.00214	CcSEcCtD
Niacin—Dermatitis—Lovastatin—atherosclerosis	0.000124	0.00214	CcSEcCtD
Niacin—Headache—Lovastatin—atherosclerosis	0.000124	0.00212	CcSEcCtD
Niacin—Vomiting—Ezetimibe—atherosclerosis	0.000123	0.00211	CcSEcCtD
Niacin—Hypersensitivity—Pravastatin—atherosclerosis	0.000123	0.00211	CcSEcCtD
Niacin—Dizziness—Simvastatin—atherosclerosis	0.000122	0.0021	CcSEcCtD
Niacin—Rash—Ezetimibe—atherosclerosis	0.000122	0.0021	CcSEcCtD
Niacin—Dermatitis—Ezetimibe—atherosclerosis	0.000122	0.00209	CcSEcCtD
Niacin—Headache—Ezetimibe—atherosclerosis	0.000121	0.00208	CcSEcCtD
Niacin—Asthenia—Pravastatin—atherosclerosis	0.00012	0.00206	CcSEcCtD
Niacin—Pruritus—Pravastatin—atherosclerosis	0.000118	0.00203	CcSEcCtD
Niacin—Vomiting—Simvastatin—atherosclerosis	0.000117	0.00202	CcSEcCtD
Niacin—Nausea—Lovastatin—atherosclerosis	0.000117	0.00201	CcSEcCtD
Niacin—Rash—Simvastatin—atherosclerosis	0.000116	0.002	CcSEcCtD
Niacin—Dermatitis—Simvastatin—atherosclerosis	0.000116	0.002	CcSEcCtD
Niacin—Headache—Simvastatin—atherosclerosis	0.000116	0.00199	CcSEcCtD
Niacin—Nausea—Ezetimibe—atherosclerosis	0.000115	0.00197	CcSEcCtD
Niacin—Diarrhoea—Pravastatin—atherosclerosis	0.000114	0.00196	CcSEcCtD
Niacin—Dizziness—Pravastatin—atherosclerosis	0.00011	0.0019	CcSEcCtD
Niacin—Nausea—Simvastatin—atherosclerosis	0.00011	0.00188	CcSEcCtD
Niacin—Vomiting—Pravastatin—atherosclerosis	0.000106	0.00182	CcSEcCtD
Niacin—Rash—Pravastatin—atherosclerosis	0.000105	0.00181	CcSEcCtD
Niacin—Dermatitis—Pravastatin—atherosclerosis	0.000105	0.00181	CcSEcCtD
Niacin—Headache—Pravastatin—atherosclerosis	0.000104	0.0018	CcSEcCtD
Niacin—Nausea—Pravastatin—atherosclerosis	9.9e-05	0.0017	CcSEcCtD
Niacin—CYP2D6—liver—atherosclerosis	9.43e-05	0.00769	CbGeAlD
Niacin—Salicylic acid—PTGS2—atherosclerosis	7.3e-05	0.529	CrCbGaD
Niacin—Salicylic acid—ALB—atherosclerosis	6.51e-05	0.471	CrCbGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.94e-05	0.000471	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APOB—atherosclerosis	2.93e-05	0.000469	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—atherosclerosis	2.9e-05	0.000465	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CETP—atherosclerosis	2.89e-05	0.000464	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PLG—atherosclerosis	2.89e-05	0.000463	CbGpPWpGaD
Niacin—QPRT—Metabolism—INS—atherosclerosis	2.89e-05	0.000462	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EDN1—atherosclerosis	2.88e-05	0.000461	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CETP—atherosclerosis	2.87e-05	0.00046	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PRKCG—atherosclerosis	2.86e-05	0.000459	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL5—atherosclerosis	2.86e-05	0.000458	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CG—atherosclerosis	2.83e-05	0.000454	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NOS3—atherosclerosis	2.83e-05	0.000454	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.81e-05	0.000451	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—LPL—atherosclerosis	2.79e-05	0.000447	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SPP1—atherosclerosis	2.79e-05	0.000447	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL8—atherosclerosis	2.78e-05	0.000445	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SCARB1—atherosclerosis	2.77e-05	0.000444	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SOD1—atherosclerosis	2.77e-05	0.000444	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—atherosclerosis	2.76e-05	0.000443	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPARG—atherosclerosis	2.74e-05	0.000438	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	2.73e-05	0.000437	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PRKCG—atherosclerosis	2.72e-05	0.000435	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCG1—atherosclerosis	2.69e-05	0.000431	CbGpPWpGaD
Niacin—NNMT—Metabolism—INS—atherosclerosis	2.68e-05	0.00043	CbGpPWpGaD
Niacin—QPRT—Metabolism—ALB—atherosclerosis	2.65e-05	0.000424	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SPP1—atherosclerosis	2.65e-05	0.000424	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL8—atherosclerosis	2.63e-05	0.000422	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF2—atherosclerosis	2.63e-05	0.000421	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMGCR—atherosclerosis	2.62e-05	0.000419	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.6e-05	0.000416	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PDGFB—atherosclerosis	2.58e-05	0.000414	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—atherosclerosis	2.57e-05	0.000411	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—APOB—atherosclerosis	2.55e-05	0.000409	CbGpPWpGaD
Niacin—QPRT—Metabolism—NOS3—atherosclerosis	2.53e-05	0.000406	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FABP4—atherosclerosis	2.53e-05	0.000405	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LCAT—atherosclerosis	2.53e-05	0.000405	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.53e-05	0.000405	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AGT—atherosclerosis	2.52e-05	0.000404	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.5e-05	0.0004	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.49e-05	0.000398	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOA4—atherosclerosis	2.48e-05	0.000398	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—LEP—atherosclerosis	2.47e-05	0.000396	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APOE—atherosclerosis	2.47e-05	0.000396	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—atherosclerosis	2.46e-05	0.000394	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PDGFB—atherosclerosis	2.45e-05	0.000392	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CAV1—atherosclerosis	2.45e-05	0.000392	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APOA1—atherosclerosis	2.44e-05	0.000391	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP7A1—atherosclerosis	2.44e-05	0.000391	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AGT—atherosclerosis	2.39e-05	0.000383	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PRKCG—atherosclerosis	2.37e-05	0.00038	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ESR1—atherosclerosis	2.36e-05	0.000378	CbGpPWpGaD
Niacin—NNMT—Metabolism—NOS3—atherosclerosis	2.35e-05	0.000377	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—atherosclerosis	2.34e-05	0.000376	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APOE—atherosclerosis	2.34e-05	0.000375	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—LEP—atherosclerosis	2.34e-05	0.000375	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCA1—atherosclerosis	2.33e-05	0.000374	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—F2—atherosclerosis	2.33e-05	0.000373	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CAV1—atherosclerosis	2.32e-05	0.000372	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CD36—atherosclerosis	2.32e-05	0.000371	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—atherosclerosis	2.32e-05	0.000371	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APOA1—atherosclerosis	2.31e-05	0.000371	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.31e-05	0.00037	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP27A1—atherosclerosis	2.25e-05	0.000361	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ESR1—atherosclerosis	2.24e-05	0.000358	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—atherosclerosis	2.23e-05	0.000357	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.21e-05	0.000354	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—F2—atherosclerosis	2.21e-05	0.000354	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—atherosclerosis	2.16e-05	0.000345	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—atherosclerosis	2.15e-05	0.000345	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PLG—atherosclerosis	2.15e-05	0.000344	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALOX15—atherosclerosis	2.14e-05	0.000342	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALOX5AP—atherosclerosis	2.14e-05	0.000342	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOA2—atherosclerosis	2.14e-05	0.000342	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLA2G2A—atherosclerosis	2.14e-05	0.000342	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PDGFB—atherosclerosis	2.14e-05	0.000342	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MAPK3—atherosclerosis	2.13e-05	0.000342	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CG—atherosclerosis	2.11e-05	0.000338	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MMP1—atherosclerosis	2.11e-05	0.000338	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCG5—atherosclerosis	2.11e-05	0.000338	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—INS—atherosclerosis	2.11e-05	0.000338	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.1e-05	0.000336	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCL2—atherosclerosis	2.08e-05	0.000333	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK3—atherosclerosis	2.06e-05	0.00033	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—atherosclerosis	2.04e-05	0.000327	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1—atherosclerosis	2.04e-05	0.000327	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPA—atherosclerosis	2.04e-05	0.000327	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CAV1—atherosclerosis	2.02e-05	0.000324	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK3—atherosclerosis	2.02e-05	0.000324	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—APOA1—atherosclerosis	2.02e-05	0.000324	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMOX1—atherosclerosis	2e-05	0.000321	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—INS—atherosclerosis	2e-05	0.00032	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—atherosclerosis	2e-05	0.00032	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.98e-05	0.000318	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BGN—atherosclerosis	1.97e-05	0.000316	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.97e-05	0.000315	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL2—atherosclerosis	1.97e-05	0.000315	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOA5—atherosclerosis	1.95e-05	0.000313	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SERPINE1—atherosclerosis	1.94e-05	0.00031	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1—atherosclerosis	1.93e-05	0.00031	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK3—atherosclerosis	1.93e-05	0.000309	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—F2—atherosclerosis	1.93e-05	0.000309	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOB—atherosclerosis	1.92e-05	0.000307	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—atherosclerosis	1.9e-05	0.000305	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—APOB—atherosclerosis	1.9e-05	0.000304	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLA2G1B—atherosclerosis	1.88e-05	0.000301	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—atherosclerosis	1.87e-05	0.0003	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—atherosclerosis	1.86e-05	0.000299	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.86e-05	0.000299	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOS3—atherosclerosis	1.85e-05	0.000296	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—atherosclerosis	1.84e-05	0.000295	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SERPINE1—atherosclerosis	1.84e-05	0.000294	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—LPL—atherosclerosis	1.83e-05	0.000293	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALOX5—atherosclerosis	1.82e-05	0.000291	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GPX1—atherosclerosis	1.79e-05	0.000286	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOS3—atherosclerosis	1.75e-05	0.000281	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.75e-05	0.00028	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CD36—atherosclerosis	1.74e-05	0.000279	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—atherosclerosis	1.69e-05	0.00027	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—atherosclerosis	1.65e-05	0.000264	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—atherosclerosis	1.64e-05	0.000263	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	1.64e-05	0.000263	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NAMPT—atherosclerosis	1.63e-05	0.000261	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LIPC—atherosclerosis	1.62e-05	0.000259	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	1.62e-05	0.000259	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARA—atherosclerosis	1.62e-05	0.000259	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOC3—atherosclerosis	1.61e-05	0.000258	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—atherosclerosis	1.6e-05	0.000257	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.6e-05	0.000257	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—atherosclerosis	1.6e-05	0.000256	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LDLR—atherosclerosis	1.6e-05	0.000256	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—atherosclerosis	1.59e-05	0.000254	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AGT—atherosclerosis	1.57e-05	0.000251	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CETP—atherosclerosis	1.56e-05	0.00025	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—atherosclerosis	1.56e-05	0.00025	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.56e-05	0.00025	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—atherosclerosis	1.56e-05	0.000249	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOE—atherosclerosis	1.53e-05	0.000246	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS3—atherosclerosis	1.53e-05	0.000245	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAV1—atherosclerosis	1.52e-05	0.000243	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOA1—atherosclerosis	1.52e-05	0.000243	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—atherosclerosis	1.51e-05	0.000241	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.5e-05	0.000241	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-05	0.000241	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SCARB1—atherosclerosis	1.5e-05	0.00024	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—atherosclerosis	1.48e-05	0.000238	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—atherosclerosis	1.48e-05	0.000237	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NFKB1—atherosclerosis	1.47e-05	0.000235	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK8—atherosclerosis	1.44e-05	0.000231	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—atherosclerosis	1.44e-05	0.000231	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMGCR—atherosclerosis	1.41e-05	0.000226	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—atherosclerosis	1.41e-05	0.000225	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NFKB1—atherosclerosis	1.39e-05	0.000223	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—atherosclerosis	1.39e-05	0.000223	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.39e-05	0.000222	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—atherosclerosis	1.38e-05	0.000222	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK8—atherosclerosis	1.37e-05	0.000219	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—atherosclerosis	1.36e-05	0.000219	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—atherosclerosis	1.34e-05	0.000214	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—atherosclerosis	1.33e-05	0.000214	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—atherosclerosis	1.32e-05	0.000211	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—INS—atherosclerosis	1.31e-05	0.00021	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—atherosclerosis	1.3e-05	0.000209	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—atherosclerosis	1.26e-05	0.000202	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—atherosclerosis	1.26e-05	0.000202	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCA1—atherosclerosis	1.26e-05	0.000202	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—atherosclerosis	1.25e-05	0.0002	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—atherosclerosis	1.22e-05	0.000196	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—atherosclerosis	1.2e-05	0.000192	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK3—atherosclerosis	1.2e-05	0.000191	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	1.19e-05	0.000191	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—atherosclerosis	1.16e-05	0.000186	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	1.16e-05	0.000186	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—atherosclerosis	1.16e-05	0.000186	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NOS3—atherosclerosis	1.15e-05	0.000184	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—atherosclerosis	1.1e-05	0.000177	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLTP—atherosclerosis	1.09e-05	0.000175	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—atherosclerosis	1.08e-05	0.000173	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMOX1—atherosclerosis	1.08e-05	0.000173	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—atherosclerosis	1.05e-05	0.000168	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—atherosclerosis	1.04e-05	0.000167	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOB—atherosclerosis	1.04e-05	0.000166	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—atherosclerosis	1.01e-05	0.000162	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000161	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPL—atherosclerosis	9.88e-06	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPX1—atherosclerosis	9.64e-06	0.000154	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LTA4H—atherosclerosis	9.48e-06	0.000152	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG8—atherosclerosis	9.48e-06	0.000152	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CD36—atherosclerosis	9.39e-06	0.00015	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—atherosclerosis	9.22e-06	0.000148	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—atherosclerosis	8.9e-06	0.000143	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—atherosclerosis	8.74e-06	0.00014	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARA—atherosclerosis	8.73e-06	0.00014	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—atherosclerosis	8.5e-06	0.000136	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AGT—atherosclerosis	8.45e-06	0.000135	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOE—atherosclerosis	8.28e-06	0.000133	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAV1—atherosclerosis	8.21e-06	0.000131	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOA1—atherosclerosis	8.19e-06	0.000131	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—atherosclerosis	8.06e-06	0.000129	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG1—atherosclerosis	7.49e-06	0.00012	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—atherosclerosis	7.48e-06	0.00012	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—atherosclerosis	7.22e-06	0.000116	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—INS—atherosclerosis	7.08e-06	0.000113	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LCAT—atherosclerosis	7.05e-06	0.000113	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FABP4—atherosclerosis	7.05e-06	0.000113	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—atherosclerosis	7.04e-06	0.000113	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOA4—atherosclerosis	6.92e-06	0.000111	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP7A1—atherosclerosis	6.79e-06	0.000109	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—atherosclerosis	6.49e-06	0.000104	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP27A1—atherosclerosis	6.28e-06	0.000101	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NOS3—atherosclerosis	6.21e-06	9.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	5.95e-06	9.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	5.95e-06	9.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOA2—atherosclerosis	5.95e-06	9.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALOX15—atherosclerosis	5.95e-06	9.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG5—atherosclerosis	5.88e-06	9.42e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPA—atherosclerosis	5.68e-06	9.1e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—atherosclerosis	5.68e-06	9.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BGN—atherosclerosis	5.5e-06	8.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOA5—atherosclerosis	5.44e-06	8.72e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—atherosclerosis	5.28e-06	8.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	5.24e-06	8.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALOX5—atherosclerosis	5.06e-06	8.11e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAMPT—atherosclerosis	4.54e-06	7.27e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LIPC—atherosclerosis	4.51e-06	7.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOC3—atherosclerosis	4.48e-06	7.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LDLR—atherosclerosis	4.46e-06	7.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CETP—atherosclerosis	4.35e-06	6.97e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SCARB1—atherosclerosis	4.17e-06	6.68e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.94e-06	6.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCA1—atherosclerosis	3.51e-06	5.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMOX1—atherosclerosis	3.01e-06	4.82e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOB—atherosclerosis	2.88e-06	4.62e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—atherosclerosis	2.85e-06	4.57e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.8e-06	4.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPL—atherosclerosis	2.75e-06	4.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX1—atherosclerosis	2.69e-06	4.3e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CD36—atherosclerosis	2.62e-06	4.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.48e-06	3.97e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARA—atherosclerosis	2.43e-06	3.9e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AGT—atherosclerosis	2.36e-06	3.77e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOE—atherosclerosis	2.31e-06	3.7e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAV1—atherosclerosis	2.29e-06	3.66e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOA1—atherosclerosis	2.28e-06	3.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.08e-06	3.34e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—atherosclerosis	2.01e-06	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—INS—atherosclerosis	1.97e-06	3.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—atherosclerosis	1.81e-06	2.9e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NOS3—atherosclerosis	1.73e-06	2.77e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.58e-06	2.53e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—atherosclerosis	7.95e-07	1.27e-05	CbGpPWpGaD
